Mustang Bio (MBIO) Times Interest Earned (2016 - 2025)
Mustang Bio (MBIO) posted quarterly Times Interest Earned of -$2.94 for Q1 2025, up 84.87% year-over-year from -$1.59 in Q1 2024, and up 62.97% quarter-over-quarter from -$7.95 in Q4 2024.
Mustang Bio (MBIO) Times Interest Earned (2016 - 2025) Analysis & Trends
Mustang Bio (MBIO) has reported Times Interest Earned for 10 consecutive years, with -$2.94 the latest figure, recorded in Q1 2025.
- In Q1 2025, Times Interest Earned rose 84.87% year-over-year to -$2.94; the TTM figure through Dec 2025 stood at -$28.28 (up 77.37% YoY), while the FY2025 annual figure was -$28.28, down 26377.36% from the prior year.
- Times Interest Earned climbed to -$2.94 in Q1 2025 per MBIO's latest filing, from -$7.95 in the prior quarter.
- Across five years, Times Interest Earned topped out at $2913.7 in Q4 2023 and bottomed at -$5692.3 in Q3 2021.
- Historically, Times Interest Earned has averaged -$921.47 across 5 years, with a median of -$19.45 in 2024.
- Annual changes were most pronounced in 2021 — Times Interest Earned sank 146589.36% — and 2023, when it soared 50285.48%.
- Mustang Bio's Times Interest Earned stood at -$5029.8 in 2021, then jumped by 99.88% to -$5.81 in 2022, then jumped by 50285.48% to $2913.7 in 2023, then tumbled by 100.27% to -$7.95 in 2024, then soared by 62.97% to -$2.94 in 2025.
- Business Quant data shows MBIO's Times Interest Earned at -$2.94 in Q1 2025, -$7.95 in Q4 2024, and -$1457.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Mustang Bio | 3.90 Mn | 3.90 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -2.94 |
| Dec 31, 2024 | -7.95 |
| Sep 30, 2024 | -1,457.00 |
| Jun 30, 2024 | -2.93 |
| Mar 31, 2024 | -19.45 |
| Dec 31, 2023 | 2,913.67 |
| Sep 30, 2023 | -2,576.75 |
| Jun 30, 2023 | -4.74 |
| Mar 31, 2023 | -15.94 |
| Dec 31, 2022 | -5.81 |
| Sep 30, 2022 | -18.23 |
| Jun 30, 2022 | -19.51 |
| Mar 31, 2022 | -85.38 |
| Dec 31, 2021 | -5,029.75 |
| Sep 30, 2021 | -5,692.33 |
| Jun 30, 2021 | -3,610.00 |
| Mar 31, 2021 | -29.99 |
| Dec 31, 2020 | -8.86 |
| Sep 30, 2020 | -3.88 |
| Jun 30, 2020 | -22.81 |